Test your knowledge on management of atrial fibrillation in patients with CLL on BTK inhibitors

Which of the following BTK inhibitors has the lowest reported rates of atrial fibrillation to date?
Ibrutinib
Acalabrutinib
Zanubrutinib
Which of the following anticoagulation strategies is contraindicated in a patient on ibrutinib who develops atrial fibrillation?
Warfarin
Apixaban
Rivaroxaban
Aspirin
Which of the following CLL therapies requires monitoring for tumor lysis syndrome?
Ibrutinib
Acalabrutinib
Zanubrutinib
Venetoclax
In the absence of del17p by FISH, what is the estimated median PFS that patients with CLL treated with ibrutinib in the frontline setting who discontinue ibrutinib due to toxicity might expect?
1 year
2 years
3 years
4 years
{"name":"Test your knowledge on management of atrial fibrillation in patients with CLL on BTK inhibitors", "url":"https://www.poll-maker.com/QQV316G60","txt":"Which of the following BTK inhibitors has the lowest reported rates of atrial fibrillation to date?, Which of the following anticoagulation strategies is contraindicated in a patient on ibrutinib who develops atrial fibrillation?, Which of the following CLL therapies requires monitoring for tumor lysis syndrome?","img":"https://www.poll-maker.com/3012/images/ogquiz.png"}
Tools: Poll Maker | Quiz Maker | Super Surveys